| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 303.93B | 309.56B | 308.34B | 285.64B | 261.10B |
| Gross Profit | 62.76B | 57.68B | 51.69B | 42.60B | 45.80B |
| EBITDA | 37.38B | 37.26B | 35.69B | 31.80B | 36.76B |
| Net Income | 13.68B | 12.74B | -10.02B | 4.59B | 12.48B |
Balance Sheet | |||||
| Total Assets | 320.10B | 303.91B | 321.94B | 331.88B | 332.79B |
| Cash, Cash Equivalents and Short-Term Investments | 74.47B | 68.16B | 74.04B | 59.54B | 55.41B |
| Total Debt | 54.56B | 57.73B | 31.18B | 34.69B | 38.86B |
| Total Liabilities | 111.83B | 109.64B | 88.39B | 91.97B | 96.76B |
| Stockholders Equity | 192.71B | 180.48B | 218.55B | 225.56B | 221.76B |
Cash Flow | |||||
| Free Cash Flow | 33.40B | 23.93B | 28.71B | 15.25B | 14.50B |
| Operating Cash Flow | 40.57B | 31.50B | 37.61B | 27.22B | 28.43B |
| Investing Cash Flow | -20.09B | -8.72B | -13.41B | -12.79B | -15.49B |
| Financing Cash Flow | -16.96B | -28.72B | -11.41B | -11.18B | -10.54B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥219.85B | 19.50 | 7.50% | 5.39% | -1.82% | 23.07% | |
74 Outperform | ¥165.85B | 13.70 | ― | 4.47% | 1.96% | 0.79% | |
71 Outperform | ¥355.32B | -8.32 | ― | 1.93% | -1.60% | -71.42% | |
68 Neutral | ¥652.35B | 28.26 | ― | 3.52% | 7.58% | 162.60% | |
66 Neutral | ¥612.63B | -13.88 | 3.35% | 3.18% | 2.15% | -6.81% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥1.73T | 6.16 | 8.34% | 2.03% | 4.53% | 65.12% |